All Stories

  1. A maternal serum metabolite ratio predicts fetal growth restriction at term
  2. GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI
  3. Authors’ reply re: Evaluation of a simple risk score to predict preterm pre‐eclampsia using maternal characteristics: a prospective cohort study
  4. Performance of different fetal weight charts in the prediction of large‐for gestational age and associated neonatal morbidity in a multi‐ethnic, obese population
  5. 4-Hydroxyglutamate is a novel predictor of pre-eclampsia
  6. Screening for breech presentation using universal late-pregnancy ultrasonography: A prospective cohort study and cost effectiveness analysis
  7. A lower maternal cortisol to cortisone ratio precedes clinical diagnosis of preterm and term preeclampsia by many weeks
  8. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study
  9. Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
  10. Blinded ultrasound fetal biometry at 36 weeks and risk of emergency Cesarean delivery in a prospective cohort study of low‐risk nulliparous women
  11. Universal vs selective ultrasonography to screen for large‐for‐gestational‐age infants and associated morbidity
  12. Reply
  13. Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta
  14. The effect of customization and use of a fetal growth standard on the association between birthweight percentile and adverse perinatal outcome
  15. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers
  16. Birth weight to placenta weight ratio and its relationship to ultrasonic measurements, maternal and neonatal morbidity: A prospective cohort study of nulliparous women
  17. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor RatioNovelty and Significance
  18. 155: Screening for late fetal growth restriction using ultrasound and the sFlt-1:PlGF ratio
  19. The pregnancy outcome prediction (POP) study: Investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes
  20. Fetal Growth and the Risk of Spontaneous Preterm Birth in a Prospective Cohort Study of Nulliparous Women
  21. Accelerated Fetal Growth Prior to Diagnosis of Gestational Diabetes Mellitus: A Prospective Cohort Study of Nulliparous Women
  22. Screening for Fetal Growth Restriction With Universal Third Trimester Ultrasonography in Nulliparous Women in the Pregnancy Outcome Prediction (POP) Study
  23. Assessing within-woman changes in mammographic density: a comparison of fully versus semi-automated area-based approaches
  24. The relationship between human placental morphometry and ultrasonic measurements of utero-placental blood flow and fetal growth
  25. 556: Universal versus selective ultrasonography to detect large for gestational age (LGA) infants
  26. 103: Accelerated fetal growth precedes diagnosis of gestational diabetes mellitus (GDM)
  27. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study
  28. 401: Fetal growth and the risk of spontaneous preterm birth
  29. 151: Screening for fetal growth restriction (FGR) using universal third trimester ultrasonography: a prospective cohort study of 3,977 nulliparous women
  30. Prediction of adolescent and adult adiposity outcomes from early life anthropometrics
  31. Life course structural equation model of the effects of prenatal and postnatal growth on adult blood pressure
  32. Infant locomotive development and its association with adult blood pressure
  33. Preschool Weight and Body Mass Index in Relation to Central Obesity and Metabolic Syndrome in Adulthood
  34. 207: First trimester placental thickness and the risk of delivering a small for gestational age infant
  35. 206: First trimester PAPP-A and the risk of fetal growth restriction
  36. LB1: Level 1 evidence for the diagnostic effectiveness of routine sonography as a screening test for small for gestational age (SGA) infants
  37. Birth size and survival in breast cancer patients from the Uppsala Birth Cohort Study
  38. Improving Prediction Algorithms for Cardiometabolic Risk in Children and Adolescents
  39. Infant Growth and Adult Obesity: Relationship and Factors Affecting Them
  40. Scoping the impact of the national child measurement programme feedback on the child obesity pathway: study protocol
  41. Social Determinants of Infant Mortality in a Historical Swedish Cohort
  42. Early and current socio-economic position and cardiometabolic risk factors in the Indian Migration Study
  43. Assessing the efficacy of the healthy eating and lifestyle programme (HELP) compared with enhanced standard care of the obese adolescent in the community: study protocol for a randomized controlled trial
  44. Maternal Hb during pregnancy and offspring's educational achievement: a prospective cohort study over 30 years
  45. Eating-Related Behaviors Measure
  46. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population
  47. Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 birth cohort study
  48. Comparison of self-reported emotional and behavioural problems in adolescents from Greece and Finland
  49. Social predictors of unsuccessful entrance into the labour market—A socialization process perspective
  50. Metabolic Cardiovascular Disease Risk Factors in Women With Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
  51. Infant Vitamin D Supplementation and Allergic Conditions in Adulthood: Northern Finland Birth Cohort 1966
  52. Social and Developmental Predictors of Optimism from Infancy to Early Adulthood
  53. Large-Scale Analysis of the Relationship betweenCYP11APromoter Variation, Polycystic Ovarian Syndrome, and Serum Testosterone
  54. Metabolic Cardiovascular Disease Risk Factors in Women with Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
  55. Relationship between birthweight and blood lipid concentrations in later life: evidence from the existing literature
  56. Hormonal Profile of Women with Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
  57. Neonatal Outcome and Congenital Malformations in Children Born After In-Vitro Fertilization
  58. Stress-Related Eating and Drinking Behavior and Body Mass Index and Predictors of This Behavior